Procter & Gamble’s Prilosec OTC still is the best-selling antacid on the market, with more than $252.7 million in annual sales for the 52 weeks ended July 8 across food, drug and mass (excluding Walmart), followed by fellow proton-pump inhibitor Novartis’ Prevacid 24HR ($104.1 million).
Colgate-Palmolive announced in late July its second-quarter results and indicated that North American business remains solid, with market share on the rise in such categories as toothpaste and manual toothbrushes.
Apparently less is more when it comes to mouthwash. According to SymphonyIRI Group data, the mouthwash segment has essentially been flat for the 12 weeks ended June 10, yet there proved to be one shining star in the mix: Listerine Zero.
While still a relatively small piece of the overall intimacy health offerings, sales of intimacy enhancement devices continue on an upward trajectory, reaching $15.5 million in overall sales on 21.8% growth for the 52 weeks ended June 10 across food, drug and mass (excluding Walmart), according to SymphonyIRI Group data.
Jarden Corp., a Germany-based condom manufacturer, will be attempting to carve out a space in mass retail with a grassroots marketing effort targeting college-age men with a message that its Billy Boy brand of condoms is not only fun, but it’s the “better built” condom.
Cereal sales are suffering as consumers resist rising prices and increasingly turn to other options, such as yogurt or frozen foods. The category also is taking a hit from an expanding menu of value-priced, on-the-go options offered by quick-serve restaurants.
Sales of sauces and marinades has been robust as consumers prepare more meals at home. A recent SymphonyIRI MarketPulse survey found that 63% of consumers eat out less frequently today than they did before the economic downturn began.